An Open-Label, Dose-Titration, Long-Term Safety Study to Evaluate CONCERTA (Methylphenidate HCL) Extended-release Tablets at Doses of 36 mg, 54 mg, 72 mg, 90 mg, and 108 mg Per Day in Adults With Attention Deficit Hyperactivity Disorder
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/studies/00004720/isLanding
下载链接
链接失效反馈官方服务:
资源简介:
The purpose of this study is to evaluate the long-term safety of methylphenidate HCL extended-release tablets at five dose levels in adults with Attention Deficit Hyperactivity Disorder (ADHD)
提供机构:
Vivli
创建时间:
2019-09-19



